Estadístiques de Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

Visites totals

views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial 124

Visites totals per mes

views
October 2024 0
November 2024 2
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

Visites al fitxer

views
alba_brjcan_trast.pdf(legacy) 64
alba_brjcan_trast.pdf 42

Vistes principals per país

views
United States 89
Spain 8
Sweden 8
Ireland 5
Belgium 3
Germany 2
Iran 2
Australia 1
Belarus 1
China 1
France 1
India 1
Russia 1

Visites principals per ciutat

views
San Ramon 19
Boardman 11
Mountain View 10
Fairfield 9
Ann Arbor 6
Dublin 5
Ashburn 4
Menlo Park 4
Cambridge 3
Erlangen 2
Las Rozas De Madrid 2
Cabañaquinta 1
Las Palmas 1
Portland 1
Rochester 1
Roquetas De Mar 1
Sacramento 1
San Diego 1
Shenzhen 1
Thane 1
Vitebsk 1
West Bloomfield 1